• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Indonesia’s Halodoc Raises Close to a Total of $100M After Latest Funding Round

Share:

July 29, 2019

Indonesia-based healthtech platform Halodoc announced that it has secured additional funding from strategic investors including the Bill & Melinda Gates Foundation, Allianz X and Prudential. Allianz and Prudential provide insurance services in Indonesia and are users of Halodoc’s services. The funds will be used to further Halodoc’s commitment to simplify healthcare through technology in Indonesia.

THE LARGER TREND

Halodoc has raised three rounds of financing from institutional investors, with the most recent funding (Series B) closed earlier this year in March, led by UOB Venture Management. Other investors in the financing round include Singtel Innov8, Korea Investment Partners and WuXi AppTec. Existing Investors such as Go-Ventures, BliBli, Openspace Ventures and Investidea also participated. In total, Halodoc has raised close to $100M (around IDR1,4 Trillion).

Halodoc operates a mobile platform for patients to access doctors any time of the day and pharmacy delivery across 50 cities, as well as home lab services, increasing accessibility to easy, affordable, and reliable healthcare services. On average, Halodoc serves around 7 million patients per month throughout Indonesia with 80% of patients residing outside the main cities of Jakarta and Surabaya.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

ON THE RECORD

“As an online healthcare application with a mission to simplify healthcare, these strategic partnerships will help improve the quality and number of healthcare options available to Indonesians living outside major cities, particularly outside of Java where healthcare infrastructure is less established. Halodoc aims to learn from the Bill & Melinda Gates Foundation’s long-established track record of working with partners to deliver best practice healthcare solutions and improving quality of life around the world,” said Jonathan Sudharta, CEO of Halodoc in a statement.

“Knowing the difficulties of healthcare accessibility in Indonesia, Halodoc is committed to new initiatives together with our investors, to help Indonesians access health services more easily. We hope, together, we can bring high quality and affordable health services across Indonesia,” Sudharta added.

Date: July 29, 2019

Source: Healthvox

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • New Pharmaceutical Track and Trace System Announced for BahrainNew Pharmaceutical Track and Trace System Announced for Bahrain
  • Global Healthcare Accreditation and the Malaysian Society for Quality in Health Announce Strategic Partnership to Offer Medical Travel Accreditation in MalaysiaGlobal Healthcare Accreditation and the Malaysian Society for Quality in Health Announce Strategic Partnership to Offer Medical Travel Accreditation in Malaysia
  • HMP Global Announces Acquisition of Kestrel Health InformationHMP Global Announces Acquisition of Kestrel Health Information
  • AVRA Medical Robotics, Inc. (OTC: AVMR) PROVIDES UPDATE ON MERGERAVRA Medical Robotics, Inc. (OTC: AVMR) PROVIDES UPDATE ON MERGER
  • Bright Health Lands $635M to Expand Medicare Advantage Plans to More MarketsBright Health Lands $635M to Expand Medicare Advantage Plans to More Markets
  • DiA Imaging Analysis Partners with Intel to Improve Ultrasound Analysis By 40%DiA Imaging Analysis Partners with Intel to Improve Ultrasound Analysis By 40%
  • Investment in Biopharma is Reaching An Inflection PointInvestment in Biopharma is Reaching An Inflection Point
  • AbCellera Expands Technology Stack with Acquisition of Trianni for $90 MillionAbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications